Coronavirus: India supplies non-JnJ vaccine under Quad umbrella
Bagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax vaccine made by the Serum Institute of India (SII), to Thailand under the Quad programme.
New Delhi: India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries, New Delhi said on Thursday, though not the Johnson & Johnson shot as originally planned.
The leaders of the Quad countries - India, the United States, Japan and Australia - could discuss the vaccine supply plan when they meet in Japan on Tuesday, Indian foreign ministry spokesperson Arindam Bagchi told a news conference.
"We have sent, under the Quad umbrella, vaccines to Cambodia and Thailand," Bagchi said.
"Yes, the original plan was to use a different modality, but the final objective is to ensure that vaccines are shared under the Quad umbrella to those countries who need them."
Bagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax vaccine made by the Serum Institute of India (SII), to Thailand under the Quad programme.
India separately shipped 325,000 doses of Covishield, a version of the AstraZeneca shot made by the SII, to Cambodia, the data shows.
The Quad was originally supposed to supply J&J doses made by Indian company Biological E Ltd to Southeast Asian and other countries, as a counter to China's vaccine donations around the world.
Biological E did not immediately respond to a request for comment. Reuters could not immediately contact J&J.
Read also: Biological E Corbevax price slashed to Rs 250 a dose
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.